Lexicon Pharmaceuticals (LXRX) EBIT Margin Growth (3y) (2013 - 2024)
Lexicon Pharmaceuticals (LXRX) EBIT Margin Growth (3y) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-904,230.00 |
| Jun 30, 2024 |
431,389.00 |
| Mar 31, 2024 |
7.30 Mn |
| Dec 31, 2023 |
-613,282.00 |
| Jun 30, 2023 |
24.44 Mn |
| Dec 31, 2021 |
899,146.00 |
| Jun 30, 2021 |
-745,539.00 |
| Mar 31, 2021 |
-7.70 Mn |
| Dec 31, 2020 |
11,681.00 |
| Jun 30, 2020 |
-25.80 Mn |
| Mar 31, 2020 |
-56,060.00 |
| Dec 31, 2019 |
-40,505.00 |
| Jun 30, 2019 |
-726.00 |
| Mar 31, 2019 |
-44,514.00 |
| Dec 31, 2018 |
-14,187.00 |
| Sep 30, 2018 |
562,087.00 |
| Jun 30, 2018 |
687,848.00 |
| Mar 31, 2018 |
133,167.00 |
| Dec 31, 2017 |
-6,938.00 |
| Sep 30, 2017 |
952,337.00 |
